Replies to post #3063 on Galectin Therapeutics Inc. (GALT)

[PaPaGriz]

From the Cerbat Gem Market News on 4/14/17:

"Several institutional investors have recently bought and sold shares of the stock. Advisor Group Inc. raised its position in Galectin Therapeutics by 3.8% in the third quarter. Advisor Group Inc. now owns 413,125 shares of the company’s stock worth $467,000 after buying an additional 15,200 shares in the last quarter. Benchmark Capital Advisors raised its position in Galectin Therapeutics by 98.3% in the third quarter. Benchmark Capital Advisors now owns 118,200 shares of the company’s stock worth $134,000 after buying an additional 58,600 shares in the last quarter. Finally, Courage Capital Management LLC purchased a new position in Galectin Therapeutics during the third quarter worth $147,000. 10.01% of the stock is owned by institutional investors and hedge funds."

I don't know these institutions or their record for picking good companies but it's about $800K of additional investment in the company.

10% institutional investment, I don't know if this includes the 10X fund.